首页> 外文期刊>Scientist >Academic Medicine to the Rescue
【24h】

Academic Medicine to the Rescue

机译:抢救学术医学

获取原文
获取原文并翻译 | 示例
           

摘要

The rate of discovery and approval of new medicines is declining despite substantially increased investment. Safety and efficacy failures are caused by:rn1. Highly novel targets, for which there is limited knowledge of the biology and role in human diseasern2. Diseases that are poorly understood in terms of patho-physiologic mechanisms, such as chronic obstructive pulmonary disease, osteoarthritis, and Alzheimer's diseasern3. Limitations in the animal models of human diseasern4. Limited biomarkers to optimize treatmentrnThe pharmaceutical industry is preeminent in moving compounds from discovery through the development phases. It's scientific and technological expertise is phenomenal - from molecular modeling to protein engineering to metabolic pathways for compounds/biologies - all are industry proficiencies.
机译:尽管投入大量资金,新药的发现和批准率却在下降。安全性和有效性失败是由于:rn1。高度新颖的靶标,对其生物学和在人类疾病中的作用的了解有限。在病理生理机制方面知之甚少的疾病,例如慢性阻塞性肺疾病,骨关节炎和阿尔茨海默氏病3。人类疾病动物模型的局限性4。有限的生物标记物可优化治疗方法制药行业在将化合物从发现转移到开发阶段方面具有举足轻重的地位。它的科学技术专长非凡,从分子建模到蛋白质工程再到化合物/生物的代谢途径,全都是行业精通。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号